CJC-1295 with DAC (Drug Affinity Complex) is a long-acting analogue of GHRH that binds covalently to
albumin in the bloodstream, extending its half-life to 6–8 days. This allows for once-weekly dosing while
maintaining elevated GH and IGF-1 levels. Unlike CJC-1295 No DAC, it produces a sustained GH bleed
rather than discrete pulses, making it suitable for those preferring less frequent injections.
Key Benefits
• Long-acting — once-weekly dosing with 6–8 day half-life
• Sustained elevation of GH and IGF-1 levels
• Supports lean muscle mass, fat loss, and recovery
• Enhanced collagen synthesis and anti-aging effects
• Convenient weekly protocol — ideal for low-frequency dosing preference
